PT  - JOURNAL ARTICLE
AU  - Reichmann, Jakob
AU  - Franz, Jonas
AU  - Eckermann, Marina
AU  - Stadelmann, Christine
AU  - Salditt, Tim
TI  - 3D imaging of protein aggregates in human neurodegeneration by multiscale X-ray phase-contrast tomography
AID  - 10.1101/2024.03.26.24304193
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.03.26.24304193
4099  - http://medrxiv.org/content/early/2024/03/27/2024.03.26.24304193.short
4100  - http://medrxiv.org/content/early/2024/03/27/2024.03.26.24304193.full
AB  - This study leverages X-ray Phase-Contrast Tomography (XPCT) for detailed analysis of neurodegenerative diseases like Alzheimer’s and Parkinson’s, focusing on the 3D visualization and quantification of neuropathological features within fixed human postmortem tissue. XPCT, utilizing synchrotron radiation, offers micrometer and even sub-micron resolution, enabling the examination of intraneuronal aggregates—Lewy bodies, granulovacuolar degeneration, Hirano bodies, and neurofibrillary tangles—and extracellular amyloid plaques and cerebral amyloid angiopathy in the fixed human tissue. This approach surpasses aspects of traditional histology, integrating with neuropathology workflows for the identification and high-resolution study of these features. It facilitates correlative studies and quantitative electron density assessments, providing insights into the structural composition and distribution of neurodegenerative pathologies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe work was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) Project-ID 432680300 - SFB 1456/A03 Mathematics of Experiment and EXC 2067/1-390729940. We also acknowledge assistance in visualization with NVIDIA IndeX (NVIDIA Corporation, USA).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee of the University Medical Center Goettingen, headed by Prof. Dr. Juergen Brockmoeller gave ethical approval for this work. Positive decision dated 20.8.2020.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Yes